Free Research Reports on CBMX, OPXA, PTEK and ZIOP Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY -- (Marketwire) -- 03/27/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

CombiMatrix Corporation (NASDAQ: CBMX) shares spiked 10.41 percent on volume of over 1 million shares traded Tuesday to close at $3.50 a share. The company reported revenues of $5.4 million for the full year 2012, an increase of 15 when compared to the full year 2011.

Find out more about CombiMatrix including full access to the free equity report at: www.BedfordReport.com/CBMX

Opexa Therapeutics Inc. (NASDAQ: OPXA) shares gained 23.70 percent on volume of over 5 million shares traded Tuesday to close at $2.61 a share. The company has eneterd into an option and license agreement with Merck Serono for the development of Tcelna for the treatment of multiple sclerosis.

Find out more about Opexa Therapeutics including full access to the free equity report at: www.BedfordReport.com/OPXA

Pokertek Inc. (NASDAQ: PTEK) shares surged 24.59 percent on volume of 1.35 million shares traded Tuesday to close at $1.52 a share. The company has announced it has renewed its contract with Carnival Corporation & plc through December 2017.

Find out more about Pokertek including full access to the free equity report at: www.BedfordReport.com/PTEK

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) shares plunged 64.52 percent on volume of over 31 million shares traded Tuesday to close at $1.82 a share. The company announced it has terminated development of its cancer drug, palifosamide, after it failed to meet its primary endpoint of progression-free survival.

Find out more about ZIOPHARM Oncology including full access to the free equity report at: www.BedfordReport.com/ZIOP

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here